XTL BIOPHARMACEUTICALS LTD. Equity And Liabilities
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Equity And Liabilities of $8.55 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2025-04-30
- 2024-12-31: Equity And Liabilities $8.55M.
- 2023-12-31: Equity And Liabilities $2.43M.
- 2022-12-31: Equity And Liabilities $4.19M.
- 2022-06-30: Equity And Liabilities $5.76M.
| Period end | Equity And Liabilities |
|---|---|
| 2024-12-31 | $8.55M 20-F · filed 2025-04-30 |
| 2023-12-31 | $2.43M 20-F · filed 2025-04-30 |
| 2022-12-31 | $4.19M 20-F · filed 2023-03-22 |
| 2022-06-30 | $5.76M 6-K · filed 2022-08-24 |
| 2021-12-31 | $6.62M 20-F · filed 2023-03-22 |
| 2021-06-30 | $6.95M 6-K · filed 2021-08-24 |
| 2020-12-31 | $6.50M 20-F · filed 2022-03-30 |
| 2019-12-31 | $7.21M 20-F/A · filed 2021-05-19 |
| 2019-01-01 | $8.57M 20-F/A · filed 2021-05-19 |
| 2018-12-31 | $8.57M 20-F · filed 2020-03-12 |
| 2017-12-31 | $6.59M 20-F · filed 2019-03-11 |
| 2016-12-31 | $3.02M 20-F · filed 2018-03-15 |